Sbc Medical Group
(NASDAQ) SBC
Sbc Medical Group Financials at a Glance
Market Cap
$458.52M
Revenue (TTM)
$173.61M
Net Income (TTM)
$50.99M
EPS (TTM)
$0.50
P/E Ratio
9.02
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Price
$4.46
Volume
659
Open
$4.26
Price
$4.46
Volume
659
Open
$4.26
Previous Close
$4.46
Daily Range
$4.25 - $4.46
52-Week Range
$2.97 - $5.75
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Price
$4.46
Volume
659
Open
$4.26
Previous Close
$4.46
Daily Range
$4.25 - $4.46
52-Week Range
$2.97 - $5.75
SBC News
SBC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sbc Medical Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
863
CEO
Yoshiyuki Aikawa, PhD
Website
sbc-holdings.comHeadquarters
Irvine, CA 92618, US
SBC Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
39%
Net Income Margin
29%
Return on Equity
23%
Return on Capital
21%
Return on Assets
13%
Earnings Yield
11.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$458.52M
Shares Outstanding
102.58M
Volume
659
Short Interest
0.00%
Avg. Volume
32.08K
Financials (TTM)
Gross Profit
$127.28M
Operating Income
$67.49M
EBITDA
$70.17M
Operating Cash Flow
$38.92M
Capital Expenditure
$2.37M
Free Cash Flow
$36.55M
Cash & ST Invst.
$164.09M
Total Debt
$51.64M
Sbc Medical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$39.57M
-10.9%
Gross Profit
$28.93M
-14.6%
Gross Margin
73.11%
N/A
Market Cap
$458.52M
N/A
Market Cap/Employee
$531.31K
N/A
Employees
863
N/A
Net Income
$14.20M
+117.2%
EBITDA
$13.52M
+93.1%
Quarterly Fundamentals
Net Cash
$112.46M
-0.3%
Accounts Receivable
$52.61M
+9.2%
Inventory
$2.79M
+86.8%
Long Term Debt
$37.99M
+390.2%
Short Term Debt
$13.65M
+205.7%
Return on Assets
13.40%
N/A
Return on Invested Capital
21.13%
N/A
Free Cash Flow
$65.29M
+927.1%
Operating Cash Flow
$66.22M
+1006.7%